218 related articles for article (PubMed ID: 32369457)
1. Complement factor H-deficient mice develop spontaneous hepatic tumors.
Laskowski J; Renner B; Pickering MC; Serkova NJ; Smith-Jones PM; Clambey ET; Nemenoff RA; Thurman JM
J Clin Invest; 2020 Aug; 130(8):4039-4054. PubMed ID: 32369457
[TBL] [Abstract][Full Text] [Related]
2. Complement factor H deficiency combined with smoking promotes retinal degeneration in a novel mouse model.
Feng L; Nie K; Huang Q; Fan W
Exp Biol Med (Maywood); 2022 Jan; 247(2):77-86. PubMed ID: 34775843
[TBL] [Abstract][Full Text] [Related]
3. Complement factor H deficiency results in decreased neuroretinal expression of Cd59a in aged mice.
Faber C; Williams J; Juel HB; Greenwood J; Nissen MH; Moss SE
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6324-30. PubMed ID: 22918646
[TBL] [Abstract][Full Text] [Related]
4. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells.
Mao X; Zhou L; Tey SK; Ma APY; Yeung CLS; Ng TH; Wong SWK; Liu BHM; Fung YME; Patz EF; Cao P; Gao Y; Yam JWP
J Extracell Vesicles; 2020 Nov; 10(1):e12031. PubMed ID: 33708358
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy.
Zanchi C; Locatelli M; Cerullo D; Aumiller V; Corna D; Rottoli D; Schubert S; Noris M; Tomasoni S; Remuzzi G; Zoja C; Benigni A
Mol Immunol; 2024 Apr; 168():10-16. PubMed ID: 38368725
[TBL] [Abstract][Full Text] [Related]
6. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.
Zhang Y; Keenan A; Dai DF; May KS; Anderson EE; Lindorfer MA; Henrich JB; Pitcher GR; Taylor RP; Smith RJ
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376801
[TBL] [Abstract][Full Text] [Related]
7. The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.
Alexander JJ; Chaves L; Chang A; Quigg RJ
Kidney Int; 2012 Nov; 82(9):961-8. PubMed ID: 22832515
[TBL] [Abstract][Full Text] [Related]
8. Complement proteins C7 and CFH control the stemness of liver cancer cells via LSF-1.
Seol HS; Lee SE; Song JS; Rhee JK; Singh SR; Chang S; Jang SJ
Cancer Lett; 2016 Mar; 372(1):24-35. PubMed ID: 26723877
[TBL] [Abstract][Full Text] [Related]
9. Expression of human complement factor H prevents age-related macular degeneration-like retina damage and kidney abnormalities in aged Cfh knockout mice.
Ding JD; Kelly U; Landowski M; Toomey CB; Groelle M; Miller C; Smith SG; Klingeborn M; Singhapricha T; Jiang H; Frank MM; Bowes Rickman C
Am J Pathol; 2015 Jan; 185(1):29-42. PubMed ID: 25447048
[TBL] [Abstract][Full Text] [Related]
10. C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.
Ruseva MM; Takahashi M; Fujita T; Pickering MC
Clin Exp Immunol; 2014 Apr; 176(1):84-92. PubMed ID: 24279761
[TBL] [Abstract][Full Text] [Related]
11. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.
Ruseva MM; Vernon KA; Lesher AM; Schwaeble WJ; Ali YM; Botto M; Cook T; Song W; Stover CM; Pickering MC
J Am Soc Nephrol; 2013 Jan; 24(1):43-52. PubMed ID: 23184055
[TBL] [Abstract][Full Text] [Related]
12. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
13. The development of atypical hemolytic uremic syndrome depends on complement C5.
de Jorge EG; Macor P; Paixão-Cavalcante D; Rose KL; Tedesco F; Cook HT; Botto M; Pickering MC
J Am Soc Nephrol; 2011 Jan; 22(1):137-45. PubMed ID: 21148255
[TBL] [Abstract][Full Text] [Related]
14. Homodimeric Minimal Factor H:
Kamala O; Malik TH; Hallam TM; Cox TE; Yang Y; Vyas F; Luli S; Connelly C; Gibson B; Smith-Jackson K; Denton H; Pappworth IY; Huang L; Kavanagh D; Pickering MC; Marchbank KJ
Front Immunol; 2021; 12():752916. PubMed ID: 34956184
[TBL] [Abstract][Full Text] [Related]
15. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
16. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice.
Fakhouri F; de Jorge EG; Brune F; Azam P; Cook HT; Pickering MC
Kidney Int; 2010 Aug; 78(3):279-86. PubMed ID: 20445496
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of microRNA-146a by hepatitis B virus X protein contributes to hepatitis development by downregulating complement factor H.
Li JF; Dai XP; Zhang W; Sun SH; Zeng Y; Zhao GY; Kou ZH; Guo Y; Yu H; Du LY; Jiang SB; Zhou YS
mBio; 2015 Mar; 6(2):. PubMed ID: 25805734
[TBL] [Abstract][Full Text] [Related]
18. Complement factor H: spatial and temporal expression and localization in the eye.
Mandal MN; Ayyagari R
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4091-7. PubMed ID: 16936129
[TBL] [Abstract][Full Text] [Related]
19. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
[TBL] [Abstract][Full Text] [Related]
20. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway.
Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY
Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
